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ABSTRACT OF THE DISSERTATION 
 
Evaluating Cognitive Changes in Patients Receiving Outpatient Alcohol Treatment 
 
by 
Michelle McDonnell 
Doctor of Philosophy, Graduate Program in Clinical Psychology 
Loma Linda University, March 2018 
Dr. Grace J. Lee, Chairperson 
 
 
Chronic alcohol use has been linked to various physical health concerns, 
neurological changes, and cognitive deficits. Research has shown that some of these 
neurologic and cognitive deficits can improve over time following detoxification and 
abstinence; however, the exact nature or timeline of this recovery process has not been 
established. The aim of the current study is to identify cognitive deficits and changes 
present in the alcohol addiction treatment population, the influence of cognitive deficits 
on treatment completion, and the effect of previous engagement in treatment (which is 
indicative of previous relapse) on cognitive functioning at both treatment onset and 
treatment completion. Results suggest that individuals within an intensive outpatient 
AUD program experienced improvements in language and overall cognitive functioning. 
Additional variables approaching significance include the subtests of story learning, 
figure copy, semantic fluency, digit span, coding, and the overall attention index, all of 
which exhibited small to medium effect sizes. In contrast, impairments in cognitive 
functioning were not related to treatment drop-out. Finally, previous treatment 
engagement was not suggestive of worse cognitive functioning. Despite reduced sample 
size, these results provide some insight into the variability in cognitive functioning within 
AUD, suggesting that providers may need to consider tailoring treatment for those who 
 ix 
present with various cognitive impairments. Programs that account for memory, 
executive functioning, and processing speed impairments may assist their patient’s in the 
retention of information presented during treatment, thus improving rehabilitation and 
increasing subsequent success in sobriety. 
 1 
CHAPTER ONE 
INTRODUCTION 
 
 The Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-
5) specifies that the diagnosis of substance use disorders requires symptoms across four 
criteria: impaired control, social impairment, risky use, and pharmacological criteria 
(2013). Individuals with a substance use disorder experience impaired control over 
substance use, cravings for the substance, failure to fulfill major role obligations, 
continued use despite physical or psychological problems, use in situations that may be 
physically hazardous, increased tolerance of the substance, and withdrawal symptoms. 
Evaluation of rates of abuse and misuse of specific substances reveals that alcohol has the 
highest rate of abuse among all drugs (National Council on Alcoholism and Drug 
Dependence, 2015). 
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), 
56.9% of people age 18 or older reported drinking alcohol in the past month, while 24.7% 
reported engaging in binge drinking, defined as a pattern of drinking that brings blood 
alcohol concentration levels to 0.008g/dL (e.g., five or more alcoholic drinks for men 
within two hours, four or more alcoholic drinks for women within two hours) within the 
past month, and 6.7% reported engaging in heavy drinking, defined as binge drinking on 
five or more days in the past month in (NIAAA, 2016). In 2015, approximately 16.3 
million adults met criteria for an Alcohol Use Disorder (AUD), and 1.5 million adults 
received treatment for an AUD from a specialized chemical dependency treatment 
program (NIAAA, 2016). The economic burden of alcohol misuse is considerable, such 
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that in 2010, it cost the United States $249 billion. Beyond economics, alcohol misuse 
has resulted in the deaths of 88,000 people in the United States and 3.3 million 
individuals worldwide in 2012 (NIAAA, 2016).  
 
Physical Health Risks of Alcohol Use 
Alcohol misuse has been found to be related to numerous health concerns 
including, but not limited to, cancer, pancreatitis, and liver disease. Increased risk of 
developing a diagnosis of pancreatitis is dose-related, such that after a threshold of four 
drinks per day, the risk of diagnosis increases proportionally to the amount of alcohol 
consumed (Irving, Samokhavalov, & Rehm, 2012). Additionally, there is a dose-response 
pattern of the effect of alcohol use on risk of cirrhosis of the liver (Day, 2006). This 
relationship can be exacerbated by body weight, type II diabetes, and genetic risk factors, 
which also may be influenced by alcohol misuse. Further evaluation of liver disease 
indicates that the median survival rate for those with a diagnosis of cirrhosis of the liver 
is approximately two years with evidence of decompensation and ten years with 
compensated cirrhosis; however, survival rates improve significantly with abstinence 
(Day, 2006). In regard to cancer, alcohol has been causally linked to squamous cell-
carcinoma of the oral cavity, pharynx, larynx, and esophagus. There is a correlational 
relationship between alcohol use and colon cancer, liver cancer, and breast cancer, as 
well as a confounding relationship between lung cancer and alcohol use, such that 
cigarette use increases during alcohol consumption (Boffetta & Hashibe, 2006).   
Alcohol misuse is not only costly at economic and global levels, but also to the 
individual’s physical and neuropsychological health. Research has indicated that there is 
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a J-shaped relationship between alcohol use and health deficits, such that minimal daily 
alcohol use may be linked to positive health benefits, while high level consumption is 
linked with negative health effects (Di Castelnuovo et al., 2006). Specifically, this dose-
dependent relationship has indicated that more than one to two drinks per day for women 
and two to four drinks per day for men increases risk for negative health concerns (Di 
Castelnuovo et al., 2006; O’Keefe, Bybee, & Lavie, 2007). In addition to the negative 
impact of chronic misuse of alcohol, those who engage in occasional misuse, such as 
binge drinking, also suffer from negative health consequences such as cancer, 
pancreatitis, and liver disease (Day, 2006; Irving, Samokhavalov, & Rehm, 2012; 
O’Keefe, Bybee, & Lavie, 2007). More specifically, even minimal alcohol consumption 
has been linked to increased risk of breast cancer in women (Shield, Soerjomataram, & 
Rehm, 2016). These negative effects are also impacted by alcohol type, such that alcohol 
consumption, with the exception of wine, is associated with increased risk for liver 
cirrhosis (Day, 2006).  
In contrast to the negative health risks associated with alcohol use, positive 
benefits of minimal to moderate alcohol use, specifically ethanol rather than particular 
components of various alcoholic beverages, has been linked to cardiovascular protection 
(O’Keefe, Bybee, & Lavie, 2007) and reduced risk for cardiovascular dementia (Deng, 
Li, Wang, Gao, & Chen, 2005; Ganguli, Vander Bilt, Saxton, Shen, & Dodge, 2005; 
Ruitenberg et al., 2002; Stampfre, Kang, Chen, Cherry, & Grodstein, 2005). Small to 
moderate amounts of alcohol consumption has been associated with lower risk of 
myocardial infarction, which is hypothesized to be attributed to the relationship between 
alcohol and HDL cholesterol, fibrinogen, and insulin sensitivity (Mukamal et al., 2005). 
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Small to moderate alcohol consumption is also associated with reduced glucose excursion 
in diabetic patients (Turner, Jenkins, Kerr, Sherwin, & Cavan, 2001), due to ethanol’s 
tendency to suppress the release of fatty acid from adipose tissue (Greenfield et al., 
2003). The relationship with alcohol consumption and abdominal weight is also 
exemplified by a J-shaped relationship, such that those who consume light amounts of 
alcohol on a daily basis have less abdominal obesity compared to non-drinkers; however, 
more than two drinks per day is associated with greater abdominal obesity in proportion 
to the number of drinks consumed per day (Dorn et al., 2003).   
 
Neurological Effects of Chronic Alcohol Use 
Alcohol misuse has also been linked to neurologic changes (Bates, Bowden, & 
Barry, 2002; Crews & Nixon, 2008; Harper, 2009; Oscar-Berman & Marinkovic, 2007; 
Sullivan & Pfefferbaum, 2005). Evidence of alterations in neurological functioning have 
been found during intoxication (Crews & Nixon, 2008), periods of binge drinking 
(Weissenborn & Duka, 2003), for patients who have been long-term alcohol users (Pitel 
et al., 2007), and even in those who are social drinkers that do not meet the criteria for an 
AUD (Harper, 2009). Neuroimaging studies have revealed volume loss in the frontal 
lobes, cerebellar vermis, and anterior hippocampus, as well as increased ventricular and 
sulcal cerebrospinal fluid (Bates, Bowden, & Barry, 2002; Harper, 2009). Evaluation of 
MRI and fMRI studies revealed that excessive consumption of alcohol results in patterns 
of circuitry disruption between the frontocerebellar neuronal nodes and connecting 
circuitry throughout the brain (Sullivan & Pfefferbaum, 2005). Oscar-Berman and 
Marinkovic (2007) found up to a 20% decrease in gray matter volume bilaterally in the 
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dorsolateral frontal cortex, as well as gray matter decrease in the temporal cortex, insula, 
thalamus, and cerebellum. Research has also found up to 10% decrease in white matter of 
the corpus callosum in chronic alcohol users (Chanraud et al., 2007; Oscar-Berman & 
Marinkovic, 2007). Neurological changes have also been found in clinically and socially 
intact alcohol-dependent individuals, such as alterations of the cerebello-thalamo-cortical 
pathways, as well as reduction in brain volume in the dorsolateral frontal lobe, temporal 
cortex, insula, thalamus, and cerebellum (Chanraud et al., 2007).  
Further evaluation of neuropsychological functioning indicates that patients with 
an AUD have significant difficulty when acquiring complex novel information (Pitel et 
al., 2007). fMRI studies indicate that, for patients with an AUD, there is increased 
cerebellar activation on tasks primarily considered to be associated with frontal lobe 
function, despite scoring within normal limits in functioning, which is indicative of a 
compensatory strategy (Pitel et al., 2007; Sullivan & Pfefferbaum, 2005). While this 
compensatory strategy may produce results within the normal range, it presents as 
ineffective and taxing, thus revealing the toll chronic alcohol use takes on the brain. 
Additional research indicates that higher-order executive functions are utilized to 
compensate for deficits in basic cognitive domain task performance (Pitel et al., 2007; 
Scheurich, 2005). More specifically, for recently detoxified men, they utilize frontal 
executive systems to perform basic visuospatial processes, such as visual perceptual 
learning and recall, to perform at the same level as normal controls, despite the fact that 
normal controls utilize more basic processes (Fama, Pfeferbaum, & Sullivan, 2004).  
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Neuropsychological Effect of Chronic Alcohol Use 
Given the neurological changes associated with alcohol use, and specifically the 
structural and functional changes within the frontal cortices, temporal cortices, and 
neuronal circuitry throughout the brain, patients’ neuropsychological functioning is also 
negatively influenced (Crews et al., 2005; Duka, Townshend, Collier, & Stephens, 2003; 
Pitel et al., 2007). The neuropsychological domains that may be affected by functional 
changes related to alcohol use include visuospatial functioning, learning and memory, 
executive functioning, language, attention, and processing speed.  
 
Visuospatial Functioning 
Alcohol use has been associated with deficits in visuospatial abilities (Crews et 
al., 2005). Those engaging in moderate to heavy alcohol consumption experience poorer 
performance in visuospatial functioning compared to healthy controls (Green et al, 2010). 
Patients with AUD exhibit deficits in visuospatial functioning, including the scanning, 
construction, and utilization and manipulation of visual information (Beatty et al., 1996). 
When compared to healthy controls, recently detoxified patients displayed reduced 
performance in the learning and construction, delayed recall, and even recognition of a 
complex figure (Dawson & Grant, 2000). Additionally, compared to healthy controls, 
recently detoxified patients presented with reduced problem-solving skills in 
organization, perceptual clustering, and constructional accuracy, which likely effects their 
ability to integrate visuospatial information in a complex design task.  
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Learning and Memory 
The impact of alcohol use and misuse on learning and memory has proven to be 
variable, based on a number of factors, including type of memory and level of alcohol 
use. Compared to healthy controls, participants engaging in moderate to heavy alcohol 
consumption exhibit poorer performances in immediate memory (e.g., list learning and 
story learning; Sullivan, Harris, & Pfefferbaum, 2010). Alcoholic patients have also been 
found to exhibit a pattern of moderate impairment across verbal and non-verbal ability 
and memory (Tivis, Beatty, Nixon, & Parsons, 1995). When evaluating learning and 
memory beyond list learning, alcohol patients exhibit impairments in their ability to learn 
complex novel information (Pitel et al., 2007). Patients with severe alcohol misuse 
resulting in Korsakoff’s Syndrome (KS) exhibit variations in memory performances such 
that they exhibit impairments on tests of explicit memory, particularly those tasks 
wherein they are not provided cues (Sullivan, Harris, & Pfefferbaum, 2010), but exhibit 
fewer impairments in verbal and non-verbal tests of implicit memory (Sullivan, Harris, & 
Pfefferbaum, 2010).  
 
Executive Functioning 
 Neuropsychological profiles of patients with mild alcoholism are likely to be 
more sensitive to frontal lobe damage than social drinkers (Duka, Townshend, Collier, & 
Stephens, 2003). Deficits in executive functioning in chronic alcohol use have been found 
in cognitive flexibility (Ratti, Bo, Giardini, & Soragna, 2002) and working memory 
(Sullivan, Harris, & Pfefferbaum, 2010). The impairments have been found to increase 
with level of alcohol use, such that those with higher levels of alcohol consumption 
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exhibit greater impairments in perseverative responding, response inhibition, and 
cognitive flexibility (Houston et al., 2014). The negative effects of heavy drinking are not 
limited to chronic users, but also effect those who engage in binge drinking or social 
drinking (Parada et al., 2012; Weissenborn & Duka, 2003). Binge drinkers have been 
found to exhibit impairments in executive functioning and the ability to retain and 
manipulate verbal working memory (backward digit span; Parada et al., 2012), while 
those who engage in acute or social alcohol use also demonstrate impairments in 
executive functioning (Weissenborn & Duka, 2003).  
 
Language, Attention, and Processing Speed 
Results concerning deficits with regard to language, attention, and processing 
speed are variable. With regard to language, alcoholic participants showed relative 
sparing in the domain of language functioning (Crews et al., 2005). In terms of attention, 
over an eight-year period, adolescents and young adults who qualify for a diagnosis of 
alcohol use disorder exhibit a decline in attentional abilities, with increased decline 
associated with longer period of use (Tapert, Granholm, Leedy, & Brown, 2002). Patients 
who have recently completed detoxification exhibit deficits in attention; furthermore, 
those who resume drinking after detoxification continue to exhibit deficits in attention 
(Bourke & Grant, 1999). With regard to processing speed, alcohol patients have been 
found to experience a pattern of moderate impairments in perceptual motor skill (Tivis, 
Beatty, Nixon, & Parsons, 1995), with heavier drinking being associated with increased 
slowing in psychomotor speed (Houston et al., 2014).  Recently detoxified male alcohol 
patients also experience deficits in psychomotor processing speed, which is further 
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exacerbated with resumed alcohol consumption after detoxification (Bourke & Grant, 
1999). This pattern continues with older male adults, such that deficits increase with age 
and older male adults perform significantly worse than their same-age peers on measures 
of psychomotor processing compared to the discrepancy found in younger males (Bourke 
& Grant, 1999).  
 
Recovery of Function after Abstinence 
Despite the neurological and neuropsychological deficits associated with alcohol 
use and AUDs, selective functional improvements and some recovery of brain mass have 
been found as a result of abstinence (Crews et al., 2005). Research has revealed that 
neurogenesis occurs during abstinence (Crews et al., 2005), and cell proliferation across 
multiple brain regions has been shown to occur as early as the first day of abstinence 
(Crews & Nixon, 2008). Nixon, Kim, Potts, He, and Crews (2008), reported cell 
proliferation throughout the hippocampus and cortex after approximately two days of 
abstinence, and as the person remains abstinent, there is increased cell proliferation 
throughout the cortex by 28 days of sobriety. MRI studies have revealed that recovering 
patients with an AUD show greater white matter volumes in the frontal lobes, greater 
cortical gray matter in the orbital frontal pole and somatosensory cortex, as well as 
reduced white matter volume in the frontal lobes, compared to active heavy drinkers 
(O’Neill, Cardenas, & Meyerhoff, 2001). Notably, frontal lobe changes are potentially 
reversible with abstinence for several months or years (Moselhy, Georgiou, & Khan, 
2001). 
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As neurological functioning and brain structures recover in abstinence, so too 
does cognitive function (Mann, Gunther, Stetter, & Ackermann, 1999). Patients who have 
received outpatient alcohol treatment exhibit improvements in executive functioning, 
verbal ability, and information processing after six weeks of abstinence; however, due to 
the small effect size, improvement may not be considered clinically significant (Bates, 
Voelbel, Buchman, Labouvie, & Barry, 2005). A meta-analysis revealed that cognitive 
deficits were still present in eleven cognitive domains, including language verbal fluency, 
processing speed, working memory, attention, executive functioning, verbal learning and 
memory, and visual learning and memory after just one month of abstinence; however, 
these deficits were resolved after one year of abstinence, even for participants who began 
treatment with minimal neuropsychological difficulties (Oscar-Berman & Marinkovic, 
2007; Stavro, Pelletier, & Potvin, 2011). Similarly, long-term abstinent males with a 
previous AUD, who remained abstinent for two years, exhibited similar 
neuropsychological results compared to healthy controls (Bourke & Grant, 1999).  While 
research has shown some cognitive improvements with long-term periods of abstinence 
(e.g., six months to a year), results assessing the older veteran population found that 
within the early stages of recovery (e.g., first two months of abstinence) they still exhibit 
deficits in verbal and nonverbal learning, with verbal learning being profoundly impaired 
(e.g., two standard deviations below same-age peers) across the learning trials, despite 
experiencing a time of abstinence (Bell, Vissicchio, & Weinstein, 2016). These results 
suggest that cognitive recovery is dependent upon time since abstinence.  
Research has been mixed with regard to the cognitive domains that undergo 
improvement. Mann, Gunther, Stetter, and Ackermann (1999) reported that after 
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approximately five weeks, the performance discrepancy between control participants and 
patients engaged in alcohol abstinence was reduced, with the exception for verbal short-
term memory. In contrast, Fein, Backhman, Fisher, and Davenport (1990), indicated that 
impairments in cognitive functioning have been found across the first five months of 
abstinence, such that half to two-thirds of abstinent alcohol exhibit these impairments; 
however, these deficits have been found to last for years after detoxification, with 
visuospatial functioning, psychomotor speed, abstract reasoning, and new learning 
experiencing the greatest impairments.  
The pattern of cognitive impairment in abstinence is impacted influenced by a 
number factors, including time since detoxification and age of onset of alcohol use (Fein, 
Bachman, Fisher, & Davenport, 1990). Specifically, those in acute detoxification (zero to 
two weeks of abstinence), exhibit deficits in attention, concentration, reaction time, motor 
coordination, motor speed, judgment, problem-solving, learning, and short-term memory 
(Fein, Bachman, Fisher, & Davenport, 1990). Patients in the intermediate-term of 
abstinence (two weeks to two months) exhibit persistent deficits in visuospatial 
processing and problem-solving. In some cases, the ability to learn new verbal material 
improves within the first two weeks of abstinence; however, it remains impaired after one 
month. Patients in the stages of long-term abstinence (greater than two months) 
experience variable results, such that while there are still improvements in cognitive 
functioning, the level of improvement varies across domain and may still not reach the 
level of same-age controls. Research is mixed with regard to improvements in long-term 
abstinence, such that some researchers indicate that cognitive deficits remain after one 
year of abstinence (Stavro, Pelletier, & Potvin, 2011).  
 12 
Age of onset of alcohol use has shown to be associated with cognitive 
impairment, such that those who begin drinking at a mean age of 14 experience 
significantly more severe impairments than those with a mean age of onset of 23, 
controlling for number of years of heavy drinking (Fein, Bachman, Fisher, & Davenport, 
1990). Within six-months, improvements in episodic memory and executive functioning 
performances can return to normal; however, this is influenced by length of alcohol 
misuse, such that those with shorter length of alcohol use and misuse experience greater 
improvements in episodic memory recovery (Pitel et al., 2009). The reversal in cognitive 
deficits throughout abstinence and AUD recovery indicates that that the brain may be 
capable of repair and restructuring throughout adulthood (Crews et al., 2005).   
Results indicate that with abstinence, many individuals with significant cognitive 
deficits exhibit at least a partial recovery from their alcohol-related cognitive impairment 
(Bates, Buckman, & Nguyen, 2013). Beyond abstinence, cognitive training has been 
associated with reduced risk for alcohol relapse up to one year after treatment (Verdejo-
Garcia, 2016). Specifically, Cognitive Bias Modification (CBM), a treatment aimed at 
modifying cognitive biases and changing how one thinks and mentally responds to 
everyday occurrences, has been found to reduce long-term alcohol use (Verdejo-Garcia, 
2016).  CBM has also been found to significantly reduce medial prefrontal cortex 
activation, which has been associated with alcohol-approach bias. Additionally, cognitive 
rehabilitation may assist in the recovery of cognitive functioning when patients are 
provided domain specific tasks, such as copying figures, decoding rhythmic signals, 
attending to and interpreting orally presented stories, multi-tasking, visual reasoning, 
recalling stories, completing crossword puzzles, and developing mnemonic strategies 
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(Allen, Goldstein, & Seaton, 1997). Cognitive rehabilitation has been linked to improved 
performance in executive functioning, memory, and other cognitive abilities, which thus 
influence the behavioral outcomes of treatment, such as abstinence and interpersonal 
relationships (Bates, Buckman, & Nguyen, 2013).  
 
Factors Related to Treatment Outcome 
Neuropsychological functioning is essential for daily functioning and has been 
found to be related to treatment outcome (Tapert, Ozyurt, Myers, & Brown, 2016). Those 
who exhibit deficits in verbal learning are likely to experience reduced effectiveness of 
verbally-based interventions and psychoeducation, thus affecting their long-term 
recovery (Bell, Vissiccio, & Weinstein, 2016). Research has found that neurocognitive 
abilities moderate the relationship between coping and treatment outcome, such that those 
with poorer neurocognitive functioning are likely to have poorer treatment outcomes 
(Tapert, Ozyurt, Myers, & Brown, 2016). These results are likely due to the fact that 
alcohol-dependent adults with neuropsychological deficits may have more difficulty 
utilizing adaptive coping skills (Tapert, Ozyurt, Myers, & Brown, 2016). Additionally, 
chronic alcohol users also suffer impairments in prospective memory for both short-term 
and long-term events, which may also influence long-term recovery (Heffernan, Moss, & 
Ling, 2002). Given the findings that poorer neurocognitive functioning is predictive of 
poorer treatment outcome, evaluation of cognitive changes within treatment are 
necessary. It will be essential to determine the neurocognitive status and changes in 
patients receiving treatment for an AUD to ensure that they have access to the best 
treatment outcomes possible.  
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Impact of Relapse on Health and Recovery 
It has been noted that relapse rates within a population of alcohol-dependent 
patients is high, such that up to 85% of the patients will relapse, even years after 
treatment. (Wiers & Heinz, 2015). Evaluation of neuroimaging suggests that, compared 
to individuals maintaining abstinence, those who relapse have been found to have 
relatively smaller volume in the orbitofrontal cortex and medial prefrontal cortex (Wiers 
& Heins, 2015), as well as altered connectivity responses in the anterior cingulate cortex 
(Zakiniaeiz, Scheinost, Seo, Sinha, & Constable, 2017). Neuroimaging studies also report 
structural changes within the amygdala, which is associated with increased craving for 
alcohol, in those who relapse compared to abstainers (Wiers & Heinz, 2015). Even 
previous relapses and detoxifications are associated with subsequent relapse behavior, as 
those with multiple previous detoxifications drink more intensely than patients without 
previous detoxifications (Malcolm, Roberts, Wang, Myrick, & Anton, 2000). Overall, 
those with less cortical volume are more likely to drink heavily during relapse (Naqvi & 
Morgenstern, 2015). This suggests that these patients are drinking significantly more 
alcohol prior to their abstinence, which may ultimately influence their cognitive 
functioning. 
 Given the complexity of recovery, it is notable that relapse can be impacted by a 
number of factors (e.g., psychosocial, neurological); however, diminished cognitive 
abilities likely add to the difficulty of maintaining abstinence (Stavro, Pelletier, & Potvin, 
2012). Evaluation of neurocognitive functioning suggests that individuals with poorer 
general cognitive skills and decision-making are at an increased risk for subsequent 
relapse (Dominguez-Salas, Diaz-Batanero, Lozano-Rojas, & Verdejo-Garcia, 2016).  
 15 
Beyond overall or general cognitive functioning, research has indicated that specific 
cognitive domains are also implicated in relapse rates. More specifically, those who have 
undergone more than one detoxification of alcohol experience increased impairments in 
visuospatial abilities, learning and memory, attentional problems, and primarily executive 
functioning (Duka, Townshend, Collier, & Stephens, 2003).  Additionally, within the 
domains of episodic memory and executive functioning, those who relapse not only 
perform significantly worse than abstainers, but also perform worse than their own 
baseline performance (Pitel et al., 2009). Working memory (as exhibited by a task such 
as the n-back task) has also been identified as indicative of subsequent relapse, with poor 
performance related to increased risk for relapse (Wiers & Heinz, 2015). Individuals who 
relapse do not show improvements in cognitive functioning or brain volume, as do those 
who remain abstinent (Pfefferbaum et al., 1995).  These studies suggest that previous 
relapse largely impacts subsequent neurological and cognitive functioning. Given the 
influence of cognitive functioning on overall recovery and health, it will be important to 
determine if previous relapse is associated with worse cognitive performance, suggestive 
of reduced recovery success.  
 
Aims and Hypotheses 
The first aim of this study is to evaluate the neurocognitive deficits and changes 
across treatment for patients receiving intensive outpatient treatment for an AUD. It is 
hypothesized that patients will exhibit improvements in their cognitive functioning at the 
end of their alcohol treatment, particularly in the domains of immediate memory, delayed 
memory, visuospatial functioning, and processing speed. The second aim of this study is 
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to identify if cognitive deficits present at the beginning of treatment are predictive of 
treatment completion. It is hypothesized that patients with poorer cognitive performance 
will have poorer treatment completion rates. The third and final aim of this study is to 
evaluate the cognitive performance within those who have undergone previous 
detoxification for AUD. Notably, it is hypothesized that overall cognitive abilities, as 
well as specific cognitive domains such as attention and memory (i.e., immediate and 
delayed) will be significantly worse for a those who have experienced previous periods of 
formal detoxification, across time points (i.e., onset of treatment, completion of 
treatment).  
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CHAPTER TWO 
METHOD 
 
Participants 
Participants were selected from the Loma Linda University Behavioral Medicine 
Center (LLUBMC), from a pool of patients who completed a seven-day inpatient 
detoxification program at the LLUBMC and received intensive outpatient chemical 
dependency treatment strictly for alcohol use disorder. Participants who qualified for 
enrollment were selected by the chemical dependency director at the LLUBMC. All 
participants were detoxified and medically stable at outpatient treatment entry. 
Participants aged 20-89 were included in this study.  
The final sample comprises 57 adults seeking intensive outpatient alcohol 
addiction treatment (age 26 to 64 years, M = 47.39, SD = 10.37; 49.1% female). In the 
current sample, 43 successfully completed their alcohol treatment, and of those 43, 20 
participants (age 26 to 63 years, M = 49.80, SD = 10.84; 55% female) were successfully 
tested after approximately three weeks of treatment.   
 
Procedures 
Participants of the chemical dependency treatment program were recruited for the 
study within two days of admission to the outpatient program, after completing an 
inpatient detoxification at the LLUBMC. Upon enrollment in the study, written informed 
consent was obtained in accordance with the procedures set by the Loma Linda 
University Institutional Review Board. Participants were then administered the 
Repeatable Battery for Neuropsychological Status (RBANS), as well as a structured 
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clinical interview regarding demographic information, as well as health, drug, and legal 
history. Participants were then re-evaluated approximately three weeks later, at the end of 
their treatment, to assess for any changes in cognitive functioning.  
 
Measures 
The RBANS (Randolph, 1998) is a brief, individually administered assessment 
battery that assesses the neuropsychological status of adults with neurologic injury or 
disease. There are 12 subtests of the RBANS: list learning, story memory, figure copy, 
line orientation, digit span, symbol digit coding, picture naming, semantic fluency, list 
recall, list recognition, story recall, and figure recall. The 12 subtests assess different 
areas of cognitive function that result in five indices: immediate memory, 
visuospatial/constructional, language, attention, and delayed memory. The Immediate 
Memory Index is composed of list learning and story memory. The Visuospatial Index is 
composed of figure copy and line orientation. The Language Index is comprised of 
picture naming and semantic fluency. The Attention index includes the digit span and 
coding subtests. Finally, the Delayed Memory Index is composed of list recall, list 
recognition, story recall, and figure recall. A total scale score provides a global measure 
of neuropsychological functioning. The RBANS utilizes a United States population-based 
normative standardization, and index scores are scaled using age-based norms. The 
RBANS has been found to demonstrate sufficient validity and reliability within the 
clinical populations of dementia (i.e., Alzheimer’s, vascular, HIV, Huntington’s, 
Parkinson’s), depression, schizophrenia, and traumatic brain injury (Randolph, 2006). 
External research also indicated that the RBANS demonstrates good validity for patients 
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within the following clinical populations: end-stage liver disease (Mooney et al., 2007), 
schizophrenia (Gold, Queern, Iannone, & Buchanan, 1999; Wilk et al., 2004), stroke 
(Green, Sinclair, Rodgers, Birks, & Lincoln, 2013), and traumatic brain injury (McKay, 
Casey, Wetheimer, & Fichtenberg 2006). 
 
Analyses 
Evaluation of the relationship of the sample demographics (e.g., gender, ethnicity, 
years of education) and cognitive performance was will be conducted. Evaluation of 
group differences for treatment completers and non-completers was conducted to 
determine if differences within demographic variables exist. Lastly, evaluation of the 
relationship between demographic variables and previous alcohol treatment was 
conducted. As there were significant differences among groups and cognitive factors, 
such variables were controlled for in subsequent analyses. Of note, age-adjusted z-scores 
and index scores were utilized for RBANS data, and thus age was not included as a 
covariate.   
The first aim of this study was to identify the cognitive changes present in patients 
receiving intensive outpatient treatment. It was hypothesized that participants will show 
improvements in the domains of immediate memory, delayed memory, visuospatial 
functioning, and processing speed. Repeated Measures Analysis of Covariance was 
conducted, comparing within-subject changes, to evaluate the effect of treatment on 
cognitive functioning (DV) across time points (IV) within RBANS Total Scores, Index 
Scores, and individual subtests. Should the demographic variables of gender, years of 
education, and ethnicity show significant relationship with variables of cognitive 
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performance, they will be controlled within the analyses. Additionally, we calculated 
Bonferroni Corrections to correct for the elevated risk of Type 1 error. Finally, reported 
effect sizes (partial eta squared) to determine the strength of any significant differences.  
 The second aim of this study was to identify if cognitive deficits present at the 
beginning of treatment are associated with treatment completion. It was hypothesized that 
participants with more prominent cognitive functioning deficits will have increased rates 
of treatment dropout. Independent samples t-tests were conducted to evaluate if cognitive 
deficits are related to dropout rates. Specifically, we evaluated each cognitive domain and 
categorical index to determine if there was a relationship between cognitive performance 
and subsequent completion of treatment. Analyses were conducted with all participants at 
the first-time point (n = 57) utilizing Treatment Completion as the independent variable. 
We conducted 18 independent samples t-tests and reporting effect sizes (Cohen’s d) to 
determine the strength of these differences. Additionally, Bonferroni correction was 
utilized to correct for Type I error. 
 The third aim of this study was to identify if there was a relationship between 
exposure to previous formal alcohol treatment and cognitive functioning. It was 
hypothesized that participants with previous formal treatment exposure will exhibit 
reduced cognitive functioning, specifically within overall cognitive functioning, 
attention, and memory (immediate and delayed), across time points. Analysis of 
Covariance (ANCOVA), controlling for ethnicity, years of education, and gender, was 
conducted to evaluate if those with previous treatment exposure will have reduced 
cognitive functioning compared to those without previous treatment exposure. Effect 
sizes (eta squared) was also be reported to indicate the strength of the relationship. 
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CHAPTER THREE 
RESULTS 
 
 Evaluation of the relationship between demographics and variables of cognitive 
performance was conducted. Results of correlation analyses revealed significant 
relationships between gender, education, and ethnicity, and various indices and individual 
subtests of cognitive functioning (see Table 1). Thus, these variables were controlled for 
in the repeated measures analysis used to investigate the first and third aim. Evaluation of 
demographic differences among treatment completers and non-completers was 
conducted. Results of Chi-Square analyses did not reveal significant differences among 
those who did and did not complete treatment for the variables of gender, ethnicity, or 
education (see Table 2). Additionally, an Independent Samples t-test showed that there 
were no significant differences between completers and non-completers for age (see 
Table 2). A Pearson Correlation was conducted, revealing no significant relationship 
between previous rehabilitation experience and demographic variables (years of 
education, gender, and ethnicity). Finally, there were no significant differences among 
demographic variables or baseline RBANS scores between the individuals who 
completed treatment and the second time point of testing compared to those who 
completed treatment without completing the second time point of testing (see Table 3). 
Given the lack of significant relationship between demographics variables and those who 
did and did not complete treatment, no demographic variables were controlled for in the 
second aim of this study.  
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Table 1. Pearson Correlations between Demographics and Cognitive Variables at the Start 
and End of Treatment. 
 Start Treatment End Treatment 
 Gender Ethnicity Education Gender Ethnicity Education 
Immediate Memory 
Index 
 0.19 -0.11 0.41** -0.25 -0.59** 0.30 
    List Learning 0.13 -0.04 0.36** -0.06 -0.50* 0.38 
    Story Memory 0.26 -0.16 0.40** -0.21 -0.36 0.05 
Visuospatial Index -0.03 -0.15 -0.40** -0.41 -0.11 0.12 
    Figure Copy -0.02 -0.08 0.37** -0.42 -0.13 -0.11 
    Line Orientation 0.01 -0.00 0.20 -0.24 -0.04 0.41 
Language Index 0.18 0.09 0.27 -0.39 -0.35 -0.13 
    Semantic Fluency 0.42** 0.07 0.25 -0.34 -0.22 -0.19 
    Picture Naming -0.04 -0.24 0.22 -0.35 -0.73** 0.35 
Attention Index 0.31* 0.16 0.21 -0.03 -0.34 -0.17 
    Digit Span 0.18 0.05 -0.01 -0.35 -0.42 -0.28 
    Coding 0.41** 0.15 0.27* 0.16 0.07 -0.08 
Delayed Memory 
Index 
0.07 -0.18 0.36** -0.02 -0.35 0.54* 
    List Recall 0.24 -0.07 0.30* 0.05 -0.15 0.53* 
    List Recognition -0.02 -0.33* 0.17 -0.11 -0.59** 0.33 
    Story Recall 0.23 0.03 0.33* -0.01 0.09 0.36 
    Figure Recall 0.07 0.01 0.34** -0.06 0.02 0.13 
Total Scale 0.24 -0.07 0.49** -0.34 -0.43 0.16 
*p < .05. **p < .01. 
 
 
Table 2. Chi-Square and Independent Samples t-test Evaluating Group Differences 
(Treatment Completion vs. Non-Completion) in Demographic Variables. 
 t p d 
Age -1.08 0.28 0.45 
 X2 p Φ 
Gender 3.14 0.07 0.24 
Ethnicity 1.26 0.53 0.15 
Education 6.01 0.20 0.33 
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Table 3. Independent Samples t-test Evaluating Differences in Demographic and RBANS 
Baseline Variables for Within Treatment Completers (Second Testing vs. Non-Second 
Testing). 
 t p d Post-Hoc 
Power 
Age -0.61 0.54 0.19 0.09 
Gender -0.24 0.81 0.07 0.06 
Education -1.69 0.10 0.52 0.38 
Immediate Memory Index -0.12 0.91 0.04 0.05 
    List Learning -0.37 0.71 0.11 0.06 
    Story Memory 0.25 0.80 0.08 0.10 
Visuospatial Index 0.20 0.84 0.06 0.08 
    Figure Copy 1.71 0.10 0.52 0.38 
    Line Orientation -0.99 0.33 0.31 0.17 
Language Index -0.60 0.55 0.19 0.09 
    Semantic Fluency -0.06 0.96 0.02 0.05 
    Picture Naming -0.72 -0.48 0.23 0.11 
Attention Index 0.71 0.48 0.22 0.11 
    Digit Span 1.21 0.23 0.38 0.23 
    Coding 0.84 0.40 0.26 0.13 
Delayed Memory Index 0.65 0.52 0.20 0.10 
    List Recall -0.41 0.69 0.12 0.07 
    List Recognition 0.99 0.33 0.30 0.16 
    Story Recall -0.18 0.86 0.06 0.05 
    Figure Recall -0.27 0.79 0.08 0.06 
Total Scale 0.41 0.68 0.13 0.07 
 
 
 Evaluation of the RBANS variables (subtests and indices) across both time points 
revealed that the following variables failed tests of normality: line orientation (treatment 
onset), picture naming (across time points), list recognition (across time points), and the 
immediate memory index (post treatment). Subsequently, the variables were transformed 
using a Log transformation (log(Xi)) in an attempt to overcome problems of outliers, 
skewness, and kurtosis. The transformations successfully rectified problems with line 
orientation, list recognition, and list recognition; however, the variables of picture naming 
(across time points), and immediate memory index (post treatment) continued to 
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demonstrate difficulties with skewness and kurtosis. Subsequently, the Square Root and 
Reciprocal Transformations were applied to the remaining variables, revealing that they 
continued to deviate from a comparable normal distribution. As such, picture naming and 
immediate memory were not utilized in the evaluation of cognitive changes across 
treatment.  Of note, there did not appear to be any significant outliers impacting the 
remaining variables of interest, therefore no participants were deleted from these results.  
 To evaluate the cognitive changes within patients receiving intensive outpatient 
treatment, 16 Repeated Measures Analysis of Covariance were conducted, one for each 
domain and index (with the exception of the variables that failed tests of normality), 
controlling for gender, years of education, and ethnicity. Note, age was not controlled for 
as we utilized age-adjusted normative data for the cognitive variables. Results indicated 
that the intensive outpatient treatment had a statistically significant effect on cognitive 
functioning on the indices of Language, F(1, 19) = 14.94, p = 0.04, 𝜂𝑝
2 = 0.48, Attention, 
F (1,19) = 8.49, p = 0.01, 𝜂𝑝
2 = 0.35, the individual subtests of Story Learning F (1, 19) = 
10.09, p = 0.006, 𝜂𝑝
2 = 0.39, Figure Copy F(1, 19) = 7.10, p = 0.02, 𝜂𝑝
2 = 0.31, Digit Span, 
F(1,19) = 4.33, p = 0.05, 𝜂𝑝
2 = 0.21, and Coding, F(1,19) = 56.37, p = 0.02, 𝜂𝑝
2 = 0.29, as 
well as the overall Total Scale F(1,19) = 17.01, p = 0.001, 𝜂𝑝
2 = 0.52. The effect sizes of 
these analyses were found to indicate medium to large effects, suggesting that the 
variables evaluated explain 21-52% of the variance in changes of cognitive functioning 
(see Table 4). Post-hoc power analyses noted that the significant variables had 50-97% 
chance of detecting a true difference. Given the minimal sample size utilized in this 
study, a Bonferroni Correction was conducted to correct for the possibility of Type I 
error, yielding an alpha value of 0.003. Subsequent review of the results suggested that 
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there was still a significant effect of intensive outpatient treatment on the Language Index 
and Total Scale (see Table 4), while the individual subtests of Story Learning (p = 0.006) 
and Semantic Fluency (p = .004) were approaching significance. Notably, a Wilcoxon 
Signed-Rank Test was conducted to evaluate the changes in cognitive functioning for the 
variables that failed the tests of normality. Results indicated that the intensive outpatient 
treatment program did not elicit a statistically significant change in the Immediate 
Memory Index (p = 0.12) or the Picture Making subtest (p = 1.00) for those enlisted a 
AUD treatment program.  
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Table 4. Repeated Measures Analysis of Covariance Evaluating Effect of Intensive 
Outpatient Treatment on Cognitive Functioning, Controlling for Gender, Education, and 
Ethnicity. 
 Start 
Treatment    
M (SD) 
End 
Treatment 
M (SD) 
F (p-value) 𝜂𝑝
2 Post-Hoc 
Power 
Immediate Memory Index b       -- -- -- -- 
List Learning -0.4 (1.2) 0.1 (0.8) 3.15 (0.09) 0.16 0.39 
Story Learning -0.3 (1.1) 0.2 (0.6) 10.09 (0.006*) 0.39 0.85 
Visuospatial Index 85.6 (15.9) 92.9 (17.9)  0.63 (0.44) 0.04 0.12 
Figure Copy -2.3 (1.9) -1.6 (1.9) 7.10 (0.02*) 0.31 0.71 
Line Orientation a 0.3 (0.2) 0.3 (0.2) 2.65 (0.12) 0.14 0.21 
Language Index 98.0 (12.1) 97.8 (12.4)  14.94 (0.001**) 0.48 0.95 
Picture Naming b -- -- -- -- -- 
Semantic Fluency 0.0 (1.2) -0.0 (1.2) 11.529 (.004*) 0.42 0.89 
Attention Index 94.7 (12.5) 102.5 (11.9)  8.49 (0.01*) 0.35 0.78 
Digit Span -0.2 (0.9) 0.0 (1.0) 4.33 (0.05*) 0.21 0.50 
Coding -0.4 (0.9) 0.2 (1.2) 6.37 (0.02*) 0.29 0.66 
Delayed 
Memory Index 
93.2 (14.9) 99.8 (12.3)  0.08 (0.78) 0.01 0.06 
List Recall -0.3 (1.4) 0.0 (1.1) 0.01 (0.94) 0.00 0.05 
List Recognition a 0.2 (0.3) 0.2 (0.2) 0.57 (0.46) 0.03 0.07 
Story Recall -0.2 (1.3) 0.3 (0.7) 1.64 (0.22) 0.09 0.23 
Figure Recall -0.6 (1.1) 0.1 (1.2) 0.30 (0.59) 0.02 0.08 
Total Scale Index 90.5 (10.8) 98.2 (11.5)  17.01 (0.001**) 0.52 0.97 
a Log Transformation applied to denoted variable. 
b Log Transformation applied to denoted variable and found to be unsuccessful. Variable 
excluded from subsequent analysis.  
*p < .05. ** p < .003 based on Bonferroni Correction.  
 
 
 To evaluate whether completers and non-completers demonstrated different levels 
of cognitive functioning at baseline, 16 Independent Samples t-tests were conducted. 
Results revealed that the poor performances on the Attention Index at baseline (t[55] =    
-2.00, p = 0.05, d = -0.54; see Table 3) was related to subsequent treatment completion. 
Evaluation of the effect size for the Attention Index, revealed that those who did not 
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complete treatment had a medium magnitude of effect (54%) for reduced attention. Post-
hoc power analyses suggested that there was a 41% chance that results capture a true 
difference. Of note, while none of the individual subtests were related to subsequent 
treatment completion, Coding (t[55] = -1.72, p = 0.09, d = -0.46) and Digit span (t[55] = -
1.86, p = 0.07, d = -0.50) showed a slight trend toward significance (see Table 4). In 
contrast, when evaluating these results utilizing the Bonferroni Correction (α = 0.003), 
calculated by dividing the number of tests analyzed by 0.05, results revealed that none of 
the cognitive domains or indices were related to treatment completion (see Table 5 and 
Table 6). A Mann-Whitney U Test was conducted to evaluate if there were significant 
differences between treatment completers and non-completers at baseline for the 
variables that failed tests of normality; there was no statistically significant differences 
for the Immediate Memory Index (p = 0.22) or the Picture Naming subtest (p = 0.50). 
 
Table 5. Independent Samples t-Test Comparing Cognitive Performance in Cognitive 
Domains among Those Who Did and Did Not Complete Treatment. 
 Treatment 
Completion 
Mean SD t df p Cohen’s 
d 
Post-Hoc 
Power 
Immediate Memory Index a  -- -- -- -- -- -- -- 
Visuospatial Index Yes 85.9 17.1 0.3 55 0.77 0.08 0.06 
 No 87.4 16.5      
Language Index Yes 96.0 11.9 -0.2 55 0.82 -0.06 0.05 
 No 95.2 10.4      
Attention Index Yes 97.3 15.7 -2.0 55 0.05* -0.54 0.41 
 No 87.1 18.8      
Delayed Memory  Yes 93.9 13.3 -1.5 55 0.14 -0.41 0.26 
Index No 87.2 17.0      
Total Scale  Yes 90.8 12.5 -1.4 55 0.15 -0.40 0.25 
Index No 84.9 15.4      
a Log Transformation applied to denoted variable and found unsuccessful. Log 
Transformation applied to denoted variable and found to be unsuccessful. Variable 
precluded from subsequent analysis.  
*p < .05. ** p < .003 based on Bonferroni correction.  
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Table 6. Independent Samples t-Test Comparing Performances in Individual Subtests 
among Those Who Did and Did Not Complete Treatment. 
 Treatment 
Completion 
Mean SD t df p Cohen’s 
d 
Post-Hoc 
Power 
List Learning Yes -0.5 1.1 -1.0 55 0.32 -0.27 0.14 
 No -0.9 -0.5      
Story Memory Yes -0.2 1.0 -0.9 55 0.37 -0.24 0.12 
 No -0.6 1.3      
Figure Copy Yes -1.8 1.8 0.4 55 0.72 0.10 0.06 
 No -1.6 1.8      
Line Orientation a Yes 0.4 0.2 -0.1 55 0.91 -0.03 0.05 
 No 0.3 0.2      
Picture Naming b -- -- -- -- -- -- -- -- 
 -- -- --      
Semantic Fluency Yes -0.1 1.3 -0.9 55 0.37 -0.24 0.12 
 No -0.4 1.1      
Digit Span Yes 0.1 1.1 -1.9 55 0.07 -0.50 0.36 
 No -0.5 1.0      
Coding Yes -0.2 1.2 -1.7 55 0.09 -0.46 0.31 
 No -0.8 1.4      
List Recall Yes -0.4 1.1 -0.0 55 0.97 -0.01 0.05 
 No -0.4 1.1      
List Recognition a Yes 0.2 0.2 1.5 55 0.15 0.39 0.24 
 No 0.3 0.3      
Story Recall Yes -0.3 1.2 -1.1 55 0.27 -0.30 0.16 
 No -0.7 1.5      
Figure Recall Yes -0.7 1.0 -0.5 55 0.60 0.28 0.15 
 No -0.9 1.4      
a Log Transformation applied to denoted variable. 
b Log Transformation applied to denoted variable and found to be unsuccessful. Variable 
precluded from subsequent analysis. 
*p < .01. **p < .003 based on Bonferroni Correction.  
 
 
Subtest and Index scores were transformed into dichotomous variables (i.e., 
categorized as impaired [z <= -1.38] or intact [z => -1.37]). Subsequently, three Binary 
Logistic Regressions were conducted, ensuring independence of observations (i.e., 
immediate and delayed domains, overall indices), evaluating effects of baseline cognitive 
functioning on treatment completion. The data was reviewed and met all assumptions 
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necessary to conduct binary logistic regressions. The binary logistic regression model 
was statistically significant for the total scale, X2(1) = 2.884, p < 0.05. In contrast, the 
individual indices and subtests remained statistically non-significant (see Table 7). Of 
note, when these results were evaluated utilizing the Bonferroni Correction (α = 0.0028), 
none of the variables was statistically significant, suggesting that baseline cognitive 
performance was not associated with treatment completion.  
 
Table 7. Results of Binary Logistic Regression Predicting Treatment Completion from 
Performance on Individual Subtests and Overall Indices. 
    95% CI 
 Wald OR p-value Lower Upper 
Immediate Memory Index 0.18 1.40 0.67 -2.34 3.28 
     List Learning 0.01 1.10 0.91 -35.64 2.45 
     Story Memory 0.49 0.39 0.48 -76.50 23.41 
Visuospatial Index 0.59 0.59 0.44 -3.47  1.09 
     Figure Copy 0.38 0.87 0.85 -19.97 1.62 
     Line Orientation 1.77 0.13 0.18 -70.47 1.05 
Language Index 0.12 0.65 0.73 -22.21 3.10 
     Semantic Fluency 0.32 1.72 0.57 -22.55 35.74 
     Picture Naming 0.96 2.78 0.33 -19.48 36.68 
Attention Index 0.58 1.84 0.45 -2.34 3.28 
     Digit Span 0.37 1.86 0.54 -40.04 39.42 
     Coding 1.93 4.49 0.17 -22.28 72.71 
Delayed Memory Index -0.02 -0.14 1.00 3.48 2.19 
     List Recall 0.00 0.97 0.98 -20.75 2.17 
     List Recognition 0.42 0.83 0.84 -20.88 1.89 
     Story Recall 2.38 3.13 0.12 -0.35 3.06 
     Figure Recall 2.20 2.71 0.14 -0.62 3.20 
Total Scale 3.94 3.86 0.04* -0.23 2.88 
*p < .05. **p < .0028 based on Bonferroni correction. 
 
 
 In order to determine if engaging in previous alcohol treatment, indicative of 
multiple relapses, influences cognitive functioning, two ANCOVAs were computed. 
Results revealed that when controlling for gender, years of education, and ethnicity, 
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previous treatment enrollment, indicative of previous relapse, was not significantly 
associated with subsequent cognitive impairments for any subtests or indices (see Table 8 
and Table 9). A Mann-Whitney U Test also revealed that previous relapse was not 
significantly associated with cognitive impairments for the Immediate Memory Index (p 
= 0.76) or the Picture Naming subtest (p = 0.46).  
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Table 8. Analysis of Covariance (ANCOVA) Testing Mean Differences in Baseline Cognitive 
Functioning Between Individuals Who Did and Did Not Attend Previous Alcohol Treatment, 
Controlling for Ethnicity, Education, and Gender. 
 Previous Treatment     
 Yes (n = 30) No (n = 27)     
 M (SD) M (SD) F(1, 55) p-value Partial 
η2 
Post-Hoc 
Power 
Immediate Memory Index b -- -- -- -- -- -- 
List Learning -0.41 (1.16) -0.87 (1.10) 0.05 0.83 0.00 0.05 
Story Memory -0.40 (1.26) -0.27 (0.86) 0.13 0.72 0.01 0.12 
Visuospatial Index 88.10 (18.31) 84.19 (15.11) 0.89 0.36 0.06 0.47 
Figure Copy -1.64 (1.89) -1.90 (1.60) 0.12 0.74 0.01 0.12 
Line Orientation a  0.32 (0.22) 0.37 (0.21) 0.05 0.83 0.00 0.05 
Language Index 97.32 (9.44) 94.15 (13.38) 0.77 0.39 0.05 0.40 
Semantic Fluency -0.01 (1.27) -0.34 (1.24) 0.07 0.80 0.01 0.12 
Picture Naming b -- -- -- -- -- -- 
Attention Index 94.47 (17.83) 95.19 (16.22)  1.41 0.25 0.09 0.64 
Digit Span -0.11 (1.20) -0.07 (1.06) 0.89 0.36 0.06 0.47 
Coding -0.44 (1.19) -0.25 (1.34) 0.52 0.28 0.03 0.26 
Delayed Memory Index 94.50 (14.93) 89.70 (13.70) 0.32 0.58 0.02 0.18 
List Recall -0.63 (1.22) -0.53 (1.04) 1.06 0.18 0.12 0.78 
List Recognition a 0.17 (0.25) 0.24 (0.25) 0.02 0.90 0.00 0.05 
Story Recall -0.52 (1.39) -0.29 (1.15) 0.80 0.39 0.05 0.40 
Figure Recall -0.63 (1.22) -0.89 (0.99) 0.62 0.44 0.04 0.33 
Total Scale 91.27 (14.73) 87.26 (11.63) 0.24 0.63 0.02 0.18 
a Log Transformation applied to denoted variable. 
b Log Transformation applied to denoted variable and found to be unsuccessful. Variable precluded 
from subsequent analysis. 
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Table 9. Results of ANCOVAs Testing Mean Differences in Post-treatment Cognitive Functioning between Individuals who Did and 
Did Not Attend Previous Alcohol Treatment, Controlling for Ethnicity, Education, and Gender. 
 Previous Treatment     
 Yes (n = 9) No (n = 11)     
 M (SD) M (SD) F(1, 18) p-value Partial η2 Post-Hoc 
Power 
Immediate Memory Index b -- -- -- -- -- -- 
List Learning -0.05 (0.79) 0.21 (0.78) 1.54 0.23 0.09 0.26 
Story Memory 0.18 (0.51) 0.19 (0.66) 0.09 0.77 0.01 0.07 
Visuospatial Index 92.33 (18.36) 93.36 (18.40) 0.00 0.95 0.00 0.05 
Figure Copy -1.64 (2.11) -1.50 (1.94) 0.02 0.88 0.00 0.05 
Line Orientation a 0.29 (0.12) 0.29 (1.99) 0.55 0.47 0.04 0.14 
Language Index 97.56 (10.17) 97.91 (14.41) 0.07 0.79 0.01 0.07 
Semantic Fluency -0.13 (1.06) 0.09 (1.42) 0.26 0.62 0.02 0.09 
Picture Naming b -- -- -- -- -- -- 
Attention Index 104.00 (11.81) 101.18 (12.34) 0.05 0.86 0.00 0.05 
Digit Span 0.06 (1.14) 0.01(0.96) 0.04 0.84 0.00 0.05 
Coding 0.43 (1.17) 0.00 (1.17) 0.59 0.45 0.04 0.14 
Delayed Memory Index 99.78 (15.41) 99.73 (9.84) 0.03 0.86 0.00 0.05 
List Recall -0.15 (1.51) 0.15 (0.63) 0.47 0.50 0.03 0.11 
List Recognition a 0.22 (0.20) 0.26 (0.28) 0.00 0.98 0.00 0.05 
Story Recall 0.29 (0.52) 0.31 (0.80) 0.01 0.94 0.00 0.05 
Figure Recall -1.17 (1.52) 0.24 (0.88) 0.43 0.52 0.03 0.11 
Total Scale 98.11 (10.09) 98.27 (13.06) 0.07 0.80 0.00 0.05 
a Log Transformation applied to denoted variable. 
b Log Transformation applied to denoted variable and found to be unsuccessful. Variable precluded from subsequent analysis. 
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CHAPTER FOUR 
DISCUSSION 
 
Alcohol consumption, and certainly AUD, has been found to be significantly 
related to subsequent cognitive impairments. Recovery from AUD has also been 
associated with improvements in cognitive functioning. Our hypothesis that patients 
receiving intensive outpatient treatment for an AUD would experience improvements in 
cognitive function was partially supported by the current study results. Specifically, the 
overall Total Scale on the RBANS improved by the end of treatment.  Further, the 
Language Index score also improved at follow-up, though this was not hypothesized. 
Additional scores in the Index of Attention, and the subtests of Story Learning, Figure 
Copy, Semantic Fluency, Digit Span, and Coding were no longer significant after 
correction for multiple comparisons. However, given the small power and the utilization 
of Bonferroni correction, these results may reflect a Type II error, or retaining the null 
hypothesis when it should be rejected. This can be assessed by interpreting the effect 
sizes of these variables, to evaluate if the improvement in scores is due to a statistical 
relationship, or by chance. The effect sizes for the variables in question show that they 
explain 21-52% of the variance in the analyses, suggesting that these values may be 
significant (prior to correction) beyond the influence of chance. Additionally, a 
retroactive power analysis suggested that there was insufficient power to detect true 
changes in List Learning, Visuospatial index, Line orientation, Delayed Recall, List 
Recall, List Recognition, Story Recall, and Figure Recall. Therefore, increasing power 
may uncover increased improvements in cognitive functioning, across subtests and 
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domains, after successful completion of outpatient treatment. Importantly, increasing the 
sample size may provide additional power to detect if truly significant effect exists.  
Improvements in cognitive functioning with abstinence have been found to be 
largely variable depending on factors of length of abstinence and patient demographics 
(e.g., age, SES, Veteran Affairs). Specifically, within the first two weeks of abstinence, 
impairments remain within all cognitive domains (Fein, Bachman, Fisher, & Davenport, 
1990), while at five weeks of abstinence, there are improvements in all domains with the 
exception of verbal short-term memory (Mann, Gunther, Stetter, Ackeramann, 1999). 
Within the first two months of detoxification, impairments within visuospatial processing 
(Fein, Backman, Fisher, & Davenport, 1990) and verbal learning remained (Bell, 
Vissicchio, & Weinstein, 2016). Furthermore, it has been noted that many individuals 
exhibit at least partial recovery from their impairments (Bates, Buckman, & Nguyen, 
2013). Notably, our results represent some variation compared to that of other studies, in 
that by the end of approximately three weeks, our sample was showing improvements on 
Language and overall cognitive functioning.  
 Our second hypothesis that baseline cognitive deficits would be more severe for 
those who dropped out of treatment compared to treatment completers was not supported, 
as the baseline cognitive differences were not significant after correcting for multiple 
comparisons. However, the effect size for the Index of Attention, suggests there may be a 
relationship beyond that of chance that was not detected due to insufficient power. This 
effect size suggests that those who previously dropped out of treatment had poorer 
performance on measures of Attention. When the sample was dichotomized into groups 
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of impaired and intact cognitive functioning across all indices, results were similarly 
insignificant after applying a Bonferroni correction.  
Our final hypothesis that previous AUD treatment, indicative of previous relapse, 
would be associated with poor cognitive functioning across treatment (beginning and end 
of treatment) was not supported. Research has indicated that cognitive impairments will 
reappear with relapse (Dominguez-Salas, Diaz-Batanero, Lozano-Rojas, & Verdejo-
Garcia, 2016; Duka, Townshend, Collier, & Stephens, 2003; Pitel et al., 2009), and may 
even be worse than the patients’ own baseline level of performance (Pitel et al., 2009). 
Notably, the sample utilized resulted in low power, based on post-hoc power analyses, 
reducing our ability to determine if the engagement in previous treatment multiple times 
reduces cognitive functioning beyond that of consistent alcohol use.  
 After correcting for multiple comparisons, findings suggest that patients engaged 
in intensive outpatient treatment for an AUD will experience general improvements in 
language and overall cognitive functioning within the three weeks of treatment or 
sobriety, but may not experience significant changes in other specific domains of 
cognition, such as memory or attention. This corroborates previous research by Fein, 
Bachman, Fisher, and Davenport (1990) indicating that regardless of the intensity of 
treatment, patients may require a greater period of sobriety to experience improvements 
in cognitive functioning. Additionally, given the low power available, it is difficult to 
determine if these results suggest that cognitive impairments are related to patient’s 
tendency to prematurely drop-out of treatment. Finally, given the negative affect of 
numerous alcohol relapses, it is important to evaluate cognitive functioning in patients 
experiencing difficulties in their recovery. The results in this study were not suggestive of 
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worse cognitive functioning when compared to other patients engaging in their first 
treatment program. Again, given the reduced power utilized in this study, it is difficult to 
determine if it is recurrent struggles with AUD, or an AUD in and of itself, that are 
related to cognitive impairments.  
 It must be noted that there are some limitations to this study. The small number of 
participants raises some questions with regard to power and significance, and prevents 
true results from being extrapolated. Additionally, the assessment battery selected for this 
study, while time efficient and appropriately brief to fit within the daily patient schedule 
in treatment, exhibits a potential weakness for utilization in the AUD population. 
Particularly, it does not contain a measure of executive functioning, which has been 
found to be significantly influenced by significant alcohol use. Additionally, while the 
RBANS has been found to have good validity and reliability, particularly as a screening 
battery for dementia (Green, Sinclair, Rodgers, Birks, & Lincoln, 2013; Gold, Queern, 
Iannone, & Buchanan, 1999; McKay, Casey, Wetheimer, & Fichtenberg 2006; Mooney 
et al., 2007; Wilk et al., 2004), it may not be viable for the unique pattern of cognitive 
performances exhibited within the AUD population. The AUD cognitive and 
neurological profile are not suggestive of permanent neurological damage (e.g., 
Traumatic brain injury, stroke, or neurodegenerative disease), which the RBANS has 
been found to have sufficient power to identify. Finally, this research fails to track 
individuals following the completion of their treatment, and thus misses the potential for 
subsequent recovery of their cognitive functioning in the long-term.  
Overall, there were improvements in language and global cognitive functioning 
for those who completed the intensive outpatient alcohol program. With increased sample 
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size, additional cognitive domains and subtests (e.g., attention, story learning, figure 
copy, semantic fluency, digit span, coding) may have displayed significant effects. 
Nevertheless,  the current study does suggest that intensive outpatient alcohol program 
can help ameliorate at least some of the cognitive consequences associated with alcohol 
use disorder.  
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